http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2241317-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc92aca39e78ff6a56fc1b6ddaa783b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4274ad7e018bee59b676e5febd2fa21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac2fb3f09e2506d4618f47d65ed0cd6
publicationDate 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2241317-A1
titleOfInvention Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
abstract The invention relates to the use of domperidone or a pharmaceutically acceptable salt thereof at low doses to prevent and/or treat a disease associated with an alteration of the immune response such as Leishmaniosis.
priorityDate 2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0848954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003216355-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5372818-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2246142-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127845679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411875152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453188736
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20056601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135747250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128953588
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448881571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136099022
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128799971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135401907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501793

Total number of triples: 56.